2020 half year results
“Despite some challenges in the first half of 2020, focusing on delivering a better customer experience has continued to deliver growth in our business.
“Strong Service NPS for both Medibank and ahm has enabled us to maintain momentum in policyholder growth with a net increase of 11,700 resident policyholders in the first half, delivering an 8 basis point increase in our market share.
“Today’s result also reflects the continuation of the higher claims environment we saw in the second half of 2019 and the investment in customer benefits such as our new Members’ Choice Advantage dental network.
“The key driver of claims growth was a 6.4% increase in prostheses cost, which was responsible for 69% of the increase of growth in hospital claims. This is extraordinary given a subdued 1.1% increase in hospital utilisation for the half.
“We are continuing to manage affordability and claims through a range of initiatives such as payment integrity, contract management and in-home care and advocating for wider reform of the industry.
“The issues that exist in the private health system are well known and we continue to lead the way in driving more reform.
“While the Government has taken progressive steps in implementing reforms, which have had some positive impact on the system, there must be recognition that additional meaningful industry cost savings and enhanced industry participation can only be realised through new Government reforms.
“That said, Medibank and the broader health system, including payors and providers, have an ongoing obligation and challenge to remove unnecessary costs from the system to ensure the future sustainability of our world class health system.
“In order to deliver affordable and sustainable care that meets customers’ changing demands, we are focused on supporting alternative settings for delivering care, giving customers greater choice and enhancing patient experience.
“The expansion of our in-home care capability has seen 4,100 patients utilise hospital in the home or rehab in the home in the first half, of which more than 2,500 were Medibank customers.
“We have done this while taking costs out of our own business and introducing more value for our customers in our products.
“Our Health Insurance costs are down 9.6% for the half, meaning that we have delivered an additional $10 million in productivity savings over the last six months, and are on track for our full year target of $20 million.
“We are working hard within our business to address the challenges, but Government and the broader private health industry must play a meaningful role to ensure that additional reforms happen as soon as possible. An absence of reform this year could further deepen the prudential regulator’s concerns regarding the overall sustainability of the industry.”
CRAIG DRUMMOND CHIEF EXECUTIVE OFFICER
Group NPAT $178.6 million, down 9.0% from $196.3 million
Group operating profit $218.8 million, down 20.9%
Operating profit of $224.2 million, down 20.4%
Premium revenue growth of 2.3%
Management expense ratio of 7.5%, down from 8.5% in 1H19
- Operating profit of $13.3 million, up 5.6%
Net investment income $38.5 million, up from $4.1 million in 1H19 in line with benchmark indices
^ Numbers presented on a continuing basis unless otherwise indicated
PERFORMANCE IN DETAIL
Group NPAT decreased by 9.0% to $178.6 million (1H19: $196.3 million). This was due to the reduction in Health Insurance operating profit, but partially offset by an increase in net investment income.
Health Insurance operating profit decreased 20.4% to $224.2 million (1H19: $281.5 million). This was driven by the continued higher claims environment and investment in customer benefits such as the new Members’ Choice Advantage dental network.
Premium revenue was up 2.3% to $3.3 billion. At a fund level, there was a net increase in resident policyholders of 11,700 or 0.7% in the first half, with improvements in the rate of acquisition and retention. Medibank retention continued to improve supported by the Live Better rewards program and Members’ Choice Advantage dental and optical networks. The ahm brand continued to grow, with policyholder growth of 4.2%.
Net claims increased by 5.9% to $2.8 billion due to a $151.9 million increase in claims expense and a $6.8 million reduction in risk equalisation receipts. Hospital claims were 6.0% higher with growth in prostheses the major driver. Extras claims were 5.6% higher, driven by investment in the Members’ Choice Advantage dental network, although this growth was partially offset by lower growth in natural therapies following regulatory reform.
Management expenses decreased by 9.6% to $248.1 million, with the management expense ratio (MER) improving from 8.5% to 7.5%. We are targeting $50 million of productivity savings across the next three years and we are on track to deliver $20 million in savings in FY20.
Operating profit was up 5.6% to $13.3 million. Medibank Health revenue was up 18.1% to $128.6 million (1H19: $108.9 million), which includes a full six months of contribution from Home Support Services (acquired in August 2018) and the new Live Better rewards program (launched in August 2019). Management expenses increased by 12.5% which includes additional investment in the home care business and Live Better, partially offset by $4.0 million in cost savings.
Net investment income increased from $4.1 million to $38.5 million in 1H20 with higher returns from both the growth and defensive portfolios. Consistent with previous practice, in order to calculate underlying NPAT for the purpose of determining the dividend for the period, we have adjusted net investment income to normalise for the impact of short-term market movements. After normalisation, the 1H20 net investment income was $39.7 million, marginally down from $39.9 million in 1H19.
Health Insurance related capital as at 31 December 2019 was $872.8 million, representing 13.0% of premium revenue, which is at the top end of the Board’s stated target range of 11.0% to 13.0%.
On the current trajectory, we continue to expect Medibank brand volumes to stabilise by the end of FY20 and grow during FY21
We expect hospital and ancillary utilisation to remain around current levels for the remainder of FY20
We also expect approximately 3% underlying claims growth per policy unit for FY20
Management expenses are expected to be approximately $540 million for FY20
We have made good progress on our productivity program and will provide an update at the FY20 result as we continue to investigate other opportunities
We are confident that Health Insurance earnings will be higher in the second half of FY20
Targeted inorganic growth for Medibank Health and Health Insurance remain areas of focus
We expect our dividend payout ratio to be at the top end or above our revised target range of 75% to 85% of underlying NPAT from total operations for FY20
We will review our capital management options with our FY20 results
Our intention remains to aspire for stronger growth in volumes at a reasonable margin
Emily Ritchie – Senior Executive, External Affairs
+61 429 642 418
Peter Kopanidis – Senior Executive, Corporate Finance
+61 3 8622 5451
All figures are in Australian dollars unless stated otherwise. Some figures, amounts, percentages, estimates, calculations of value and fractions are subject to rounding. Accordingly, the actual calculations of these figures may differ from figures set out in this document. Further, some balances subject to rounding, may not add consistently throughout the document.
For a complete list of all ASX announcements, please visit our Investor Centre.